MX9102446A - Solucion acuosa, estable, de calcitonina y metodo para su produccion. - Google Patents

Solucion acuosa, estable, de calcitonina y metodo para su produccion.

Info

Publication number
MX9102446A
MX9102446A MX9102446A MX9102446A MX9102446A MX 9102446 A MX9102446 A MX 9102446A MX 9102446 A MX9102446 A MX 9102446A MX 9102446 A MX9102446 A MX 9102446A MX 9102446 A MX9102446 A MX 9102446A
Authority
MX
Mexico
Prior art keywords
stable
aqueous
production
acid
hct
Prior art date
Application number
MX9102446A
Other languages
English (en)
Inventor
Tudor Arvinte
Katherine Diana
Ryman
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909026882A external-priority patent/GB9026882D0/en
Priority claimed from GB919119048A external-priority patent/GB9119048D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9102446A publication Critical patent/MX9102446A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Compounds Of Unknown Constitution (AREA)
MX9102446A 1990-12-11 1991-12-09 Solucion acuosa, estable, de calcitonina y metodo para su produccion. MX9102446A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909026882A GB9026882D0 (en) 1990-12-11 1990-12-11 Pharmaceutical compositions
GB919119048A GB9119048D0 (en) 1991-09-06 1991-09-06 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX9102446A true MX9102446A (es) 1992-07-01

Family

ID=26298092

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102446A MX9102446A (es) 1990-12-11 1991-12-09 Solucion acuosa, estable, de calcitonina y metodo para su produccion.

Country Status (16)

Country Link
EP (1) EP0490549B1 (es)
JP (1) JP3179538B2 (es)
KR (1) KR100253862B1 (es)
AT (1) ATE124869T1 (es)
AU (1) AU653371B2 (es)
CA (1) CA2057291C (es)
DE (1) DE69111205T2 (es)
DK (1) DK0490549T3 (es)
ES (1) ES2074236T3 (es)
HU (1) HU213204B (es)
IE (1) IE66398B1 (es)
IL (1) IL100239A (es)
MX (1) MX9102446A (es)
NZ (1) NZ240901A (es)
PH (1) PH30776A (es)
PT (1) PT99727B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5541155A (en) * 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5397479A (en) * 1993-04-26 1995-03-14 International Remote Imaging Systems, Inc. Composition and method for enrichment of white blood cells from whole human blood
DE726075T1 (de) * 1995-02-08 1996-12-12 Therapicon Srl Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
EP0904065A4 (en) 1996-06-14 2000-06-14 Emisphere Tech Inc MICRO-ENCLOSED FRAGRANCES AND PRODUCTION METHOD
US5726154A (en) * 1996-06-28 1998-03-10 University Of Utah Research Foundation Stabilization and oral delivery of calcitonin
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
EP1232753B1 (en) * 1999-09-08 2008-03-19 Chugai Seiyaku Kabushiki Kaisha Stable protein solution filled in a container made from a hydrophobic resin and method of stabilizing the same
JP3498041B2 (ja) * 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
KR20080031684A (ko) 2005-06-14 2008-04-10 암젠 인코포레이티드 자가 - 완충성 단백질 제형
EP2471554A1 (en) * 2010-12-28 2012-07-04 Hexal AG Pharmaceutical formulation comprising a biopharmaceutical drug
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
BR112019007858A2 (pt) 2016-10-21 2019-07-02 Amgen Inc formulações farmacêuticas e métodos para produzir as mesmas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657858A5 (de) * 1983-06-27 1986-09-30 Ciba Geigy Ag Substanz aus der gruppe der calcitonine.
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
ES2058351T3 (es) * 1988-01-29 1994-11-01 Sumitomo Pharma Un procedimiento para producir una formulacion de liberacion sostenida que es adecuada para el uso humano y veterinario.
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH02174726A (ja) * 1988-12-23 1990-07-06 Toyo Jozo Co Ltd エルカトニン水溶液組成物の安定化法
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物

Also Published As

Publication number Publication date
PT99727B (pt) 1999-05-31
DK0490549T3 (da) 1995-08-21
KR920011516A (ko) 1992-07-24
HUT59832A (en) 1992-07-28
DE69111205T2 (de) 1996-01-04
NZ240901A (en) 1993-03-26
CA2057291A1 (en) 1992-06-12
EP0490549A1 (en) 1992-06-17
IE914294A1 (en) 1992-06-17
JPH06340547A (ja) 1994-12-13
CA2057291C (en) 2003-09-09
IE66398B1 (en) 1995-12-27
EP0490549B1 (en) 1995-07-12
HU913887D0 (en) 1992-02-28
IL100239A0 (en) 1992-09-06
PT99727A (pt) 1992-10-30
DE69111205D1 (de) 1995-08-17
ES2074236T3 (es) 1995-09-01
HU213204B (en) 1997-03-28
KR100253862B1 (ko) 2000-09-01
JP3179538B2 (ja) 2001-06-25
PH30776A (en) 1997-10-17
ATE124869T1 (de) 1995-07-15
AU653371B2 (en) 1994-09-29
AU8889891A (en) 1992-06-18
IL100239A (en) 1996-06-18

Similar Documents

Publication Publication Date Title
MX9102446A (es) Solucion acuosa, estable, de calcitonina y metodo para su produccion.
ES2014309T5 (es) Utilizacion de una sal para influenciar el vertido de composiciones espesas.
FR2633929B2 (fr) Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
TR26748A (tr) SU VE N-METIL-MORFOLIN-N-OKSIT ICINDE SELüLOZ CÖZELTISI.
NO903691D0 (no) Vandige aldehydopploesninger for oppfangelse av hydrogensulfid.
DK199789A (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
SE8801710D0 (sv) New ophtalmological composition of matter
DE69007546D1 (de) Haarbehandlungszusammensetzung.
ES2053101T3 (es) Compuesto detergente para la piel.
ATE326215T1 (de) Verwendung einer wässrigen lösung oder suspension zum heilen des hornhautepithels
JPS6413016A (en) Skin external preparation
DE59006292D1 (de) Wässrige Lösungen von Natriumsalzen des Trimercapto-s-triazins, deren Herstellung und Verwendung.
PT92483A (pt) Processo para a preparacao de solucoes aquosas de doxorubicina
RU95120762A (ru) Способ лечения острого ринофаринголарингита
SE8500715D0 (sv) Sett vid pappersframstellning
FR2621039B1 (fr) Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
IT8621532A0 (it) Derivati dell'acido 2,2-dimetil-ciclopropancarbossilico .
DK214884D0 (da) Chlorphenoxyacetatderivat
ES8300783A1 (es) Procedimiento para la produccion de transplantados esclero- proteinicos de estabilidad biologica acrecentada
TH1653A (th) Grf ของตับอ่อนของคน
UA6239A1 (uk) Спосіб одержання 3,9-диєтил-3'-(3-сульфопропіл)-5-метокси-4',5'-бензотиакарбоціанинбетаіна